Loading

GOVERNMENT

  • by Justin Strekal, NORML Political Director April 19, 2018

    In a video tweet posted on Vice News, Leader Schumer says:

    “I’ll be introducing legislation to decriminalize marijuana at the federal level, from one end of the country to the other.”

    With this announcement, Senator Schumer has effectively made it clear that a legislative priority for the Democratic Party is to end the federal prohibition of marijuana. As Democratic Leader, it is his role to ensure that the caucus as a whole falls in line with this public policy position — a position that is held by more than 60 percent of Americans.

    This legislative relief must come sooner rather than later. Over 600,000 Americans, a disproportionate percentage of which are black, brown, young, and poor, are arrested for violating marijuana laws annually. These people bear the greatest burden and lifelong consequences of this ongoing failed federal policy, and it is time for Congressional leaders to take a stand to right these past wrongs.

    Vice reports: “The legislation, which his office expects will be released within the next week, has six main points. First, it would remove marijuana from Drug Enforcement Administration’s list of controlled substances, which would end federal prohibition and leave it up to states to decide how to regulate the drug. Schumer stopped short of calling it legalization, but de-scheduling would essentially make marijuana legal at the federal level.”

    With Chuck Schumer now joining Senators Bernie Sanders, Cory Booker, Kirsten Gillibrand, and Ron Wyden in sponsoring comprehensive marijuana law reform legislation, it is time for the Democratic party to speak with one voice. The Party must be clear and consistent in their intent to legalize marijuana, as well as expunge the criminal convictions that hold millions of Americans back from basic needs like employment, housing, and pathways to higher education.

    As states start dialing back their war on marijuana consumers, it is important that those who were impacted by this oppressive prohibition are able to see previous harms remedied, and be provided the opportunity to participate in the benefits that come along with legalization and regulation. We fully applaud Senator Schumer acknowledging this reality with today’s announcement.

    More information about Senator Schumer’s bill to come in the days ahead. 

  • by NORML

    Today, Senator Bernie Sanders joined Senator Cory Booker on a live stream for a conversation about ending prohibition and co-sponsoring the Marijuana Justice Act.

    But they can’t do it alone.

    Right now, 33 members of Congress have put their name on the House and Senate versions of this legislation, but we still have a long way to go. Politicians are starting to realize that legalization is not only good policy, but good politics. Send a message to your federal officials and tell them to put their name on this legislation too.

    The ongoing enforcement of cannabis prohibition financially burdens taxpayers, encroaches upon civil liberties, engenders disrespect for the law, impedes legitimate scientific research into the plant’s medicinal properties, and disproportionately impacts communities of color. The Marijuana Justice Act would be the sensible, moral, and rational way to end the failed policy of marijuana criminalization.

    In 2016, over 650,000 people were arrested for marijuana. The consequences are staggering. From time spent in jail to the costs of legal fees – to the collateral consequences, including but not limited to having to list a criminal offense on a job or housing application, the criminalization of cannabis is a cruel concept that most hurts those in poverty and is disproportionately enforced against people of color.

    Don’t wait until 4/20 to take action. Send a message to your lawmakers NOW.

    Thanks for standing up, speaking out, and being a NORML citizen.

    Your friends at National NORML.

  • by Paul Armentano, NORML Deputy Director April 18, 2018

    United States Rep. Timothy Waltz (D-MN), along with over 30 bipartisan co-sponsors, has introduced legislation, HR 5520: The VA Medicinal Cannabis Research Act of 2018, to facilitate federally-sponsored clinical research into the safety and efficacy of medical cannabis among veterans.

    The legislation states: “In carrying out the responsibilities of the Secretary of Veterans Affairs, … the Secretary may conduct and support research relating to the efficacy and safety of forms of cannabis … on the health outcomes of covered veterans diagnosed with chronic pain, post-traumatic stress disorder, and other conditions the Secretary determines appropriate.”

    According to nationwide survey data compiled by The American Legion, 39 percent of respondents affirmed that they “know a veteran” who is using the plant medicinally. Twenty-two percent of respondents said they themselves “use cannabis to treat a mental or physical condition.” Yet, VA Secretary David Shulkin has consistently rejected calls from veterans groups and lawmakers to study the use of cannabis among military veterans.

    Passage of HR 5520 explicitly authorizes “the Secretary to conduct and support research on the efficacy and safety of medicinal cannabis.”

    Representative Walz, who is the ranking member of the House VA committee, said: “While we know cannabis can have life-saving effects on veterans suffering from chronic pain or PTSD, there has been a severe lack of research studying the full effect of medicinal cannabis on these veterans. Simply put, there is no department or organization better suited to conduct this critically important research than VA, and there will never be a better time to act.”

    Please click here to urge your federal lawmakers to support HR 5520: The VA Medicinal Cannabis Research Act of 2018.

  • by NORML April 11, 2018

    It has been announced that former Republican Speaker of the House John Boehner, along with former Republican Governor of Massachusetts Bill Weld, have joined the Board of Advisors for Acreage Holdings, a multi-state corporation operating in the medical and recreational marijuana space. The company holds licenses for dozens of cannabis businesses in the United States.

    Boehner, in comments to the press, made it clear that he has reversed his long held opposition to marijuana legalization. In an interview with Bloomberg news wire, he stated: “Over the last 10 or 15 years, the American people’s attitudes have changed dramatically. I find myself in that same position.”

    In response to this announcement, NORML Executive Director Erik Altieri issued the following statement:

    “John Boehner’s evolution on marijuana legalization mirrors that of both the American public in general and Republicans specifically. Recent polling finds that over 60 percent of Americans support adult use marijuana legalization and, for the first time, this percentage includes a majority of self-identified Republicans. Allowing states the flexibility and autonomy to set their own marijuana regulatory policies is consistent with conservatives’ long-held respect for the Tenth Amendment, as well as with the party’s recent embracing of populism.”

    Altieri continued, “Regardless of motive, former Speaker Boehner is still held in high regard by a large percentage of the GOP membership and voter base. We look forward to his voice joining the growing chorus calling for an end to cannabis criminalization. Anything that expedites the ability for patients to access this safe and reliable treatment alternative, and that facilitates an end to the practice of arresting otherwise law abiding citizens for the possession of a plant should be welcomed with open arms.”

  • by Justin Strekal, NORML Political Director April 10, 2018

    …At least that’s how the public comment process works. 

    This year, the United Nations World Health Organization is due to review the current international classification of marijuana, THC, cannabidiol, and other related compounds and preparations this year. In the lead-up, the WHO is asking member nations submit feedback, of which no nation is more influential than the United States.

    Between now and April 23rd, the U.S. Food and Drug Administration is seeking public comment from “interested persons” (I.E. you) regarding the international Schedule 1 Status of marijuana under international agreements.

    We have made it incredibly easy for you to make your voice heard and need you to join your voice with thousands of other NORML members in making it clear: Cannabis does not fit in a controlled substances agreement, let alone Schedule 1.

    Click here to submit a comment. 

    Right now, we are collecting comments and will be delivering them by hand to the FDA offices on April 23rd.

    In the action alert, you will find a pre-drafted comment that we encourage you to amend and include any other important aspects you deem worthy. You can draw additional information from our Factsheets and About Marijuana pages to expand your position for these public comments.

    Don’t forget, democracy is not a spectator sport. Go on record with the FDA and fill out a comment to recommend the international descheduling of marijuana NOW.

Page 3 of 14212345...102030...Last »